Assessment of liver steatosis and liver damage in patients with ulcerative colitis

Introduction Recent data indicate that hepatic steatosis is higher in patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC). We have recently shown that TNFα treatment is associated with lower rates of steatosis in patients with Crohn's disease compared to controls. This could be related to a reduction of IBD-specific risk factors like intestinal inflammation. This study aimed to examine the hepatic status in patients with UC compared to patients with IBS who lack intestinal inflammation.